BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 235638)

  • 21. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigabatrin attenuates the development and expression of tolerance to morphine-induced antinociception in mice.
    Chavooshi B; Saberi M; Pournaghash Tehrani S; Bakhtiarian A; Ahmadiani A; Haghparast A
    Pharmacol Biochem Behav; 2009 Aug; 93(2):155-9. PubMed ID: 19446576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic control of opiate-induced locomotor activity in mice.
    Judson BA; Goldstein A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):56-60. PubMed ID: 207859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
    Lange DG; Fujimoto JM; Roerig S; Wang RI
    Drug Metab Dispos; 1977; 5(2):167-73. PubMed ID: 15809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
    Medina Jiménez M; Luján Estrada M; Rodríguez R
    Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice.
    Fish EW; DeBold JF; Miczek KA
    Psychopharmacology (Berl); 2002 Feb; 160(1):39-48. PubMed ID: 11862372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
    Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
    Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice.
    Yoshida M; Ohdo S; Takane H; Tomiyoshi Y; Matsuo A; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1200-5. PubMed ID: 12626644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ.
    Varnado-Rhodes Y; Gunther J; Terman GW; Chavkin C
    Proc West Pharmacol Soc; 2000; 43():15-7. PubMed ID: 11056944
    [No Abstract]   [Full Text] [Related]  

  • 34. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization.
    Leite-Morris KA; Fukudome EY; Shoeb MH; Kaplan GB
    J Pharmacol Exp Ther; 2004 Feb; 308(2):667-78. PubMed ID: 14610238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine analgesia in mice of different ages.
    Webster GW; Shuster L; Eleftheriou BE
    Exp Aging Res; 1976 May; 2(3):221-33. PubMed ID: 190016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hydroxylamine on the consequences of long-lasting administration of morphine in mice. I. Effect on the morphine tolerance.
    Reinis S
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):222-9. PubMed ID: 1172415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of acute lethality of narcotic analgesics in aggregated and isolated mice by the central cholinomimetic action of pilocarpine.
    Brister CC; Davis WM
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):298-305. PubMed ID: 4155280
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross reverse tolerance between amphetamine, cocaine and morphine.
    Hijikuro K; Kaneto H
    J Pharmacobiodyn; 1987 Sep; 10(9):503-5. PubMed ID: 3437393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic activities of amphetamine isomers.
    Tocco DR; Maickel RP
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):25-31. PubMed ID: 6732359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.